Sage Therapeutics (NASDAQ:SAGE) Stock Rating Reaffirmed by Needham & Company LLC
Sage Therapeutics (NASDAQ:SAGE – Get Free Report)‘s stock had its “hold” rating reaffirmed by investment analysts at Needham & Company LLC in a report released on Thursday, Benzinga reports. Several other equities research analysts have also commented on SAGE. Bank of America decreased their price objective on shares of Sage Therapeutics from $11.00 to $6.00 […]
17 Oct 09:32 · The Cerbat Gem